Physician profile
James D Brooks
NPI 1447542840
$11,424.45
in general payments reported to CMS, 2019-2025
16 companies · $722 in 2025
The $722 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,754 · 2020: $1,149 · 2021: $2,899 · 2022: $1,800 · 2023: $1,677 · 2024: $1,424 · 2025: $722.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,822.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $2,061.53 | 2021 | |
| Getinge USA Sales, LLC | $1,946.15 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $1,781.09 | 2021-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Aaa Endoprosthesis |
| Boston Scientific Corporation | $1,382.12 | 2022-2025 | Eluvia, Enroute Transcarotid Neuroprotection System |
| Cook Medical LLC | $1,336.19 | 2019-2025 | Zenith Spiral-Z, Zenith, Zilver Ptx |
| Medtronic, INC. | $1,173.89 | 2021-2024 | Endurant Iis |
| Medtronic Vascular, INC. | $865.61 | 2019-2020 | |
| Shockwave Medical, INC | $342.58 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Silk Road Medical, INC. | $231.51 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Penumbra, INC. | $143.43 | 2023 | Penumbra System |
| Terumo Medical Corporation | $32.64 | 2023 | R2p Misago |
| Abbott Laboratories | $29.65 | 2020-2021 | |
| Cvrx, INC. | $29.37 | 2025 | Barostim Neo System |
| Lemaitre Vascular, INC. | $28.91 | 2024 | Artegraft Vascular Graft |
| Baxter Healthcare | $24.55 | 2024 | Floseal |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $15.23 | 2023 | Prevena, V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.